FDA Inspection 1144549 — Miyoshi America, Inc
The FDA completed an inspection of Miyoshi America, Inc on May 25, 2021 in Dayville, CT. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI)
- End Date
- May 25, 2021
- Fiscal Year
- 2021
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Dayville, CT (United States)